Gene amplification of EGFR, HER2, HER3 and HER4 in esophageal squamous cell carcinoma

被引：0
|
作者：
Kato, Hiroaki [1 ]
Arao, Tokuzo [2 ]
Matsumoto, Kazuko [2 ]
Fujita, Yoshihiko [2 ]
Kimura, Hideharu [2 ]
Nishiki, Kouhei [1 ]
Shiraishi, Osamu [1 ]
Yasuda, Atsushi [1 ]
Peng, Ying-Feng [1 ]
Shinkai, Masayuki [1 ]
Imano, Motohiro [1 ]
Imamoto, Haruhiko [1 ]
Yasuda, Takushi [1 ]
Okuno, Kiyotaka [1 ]
Shiozaki, Hitoshi [1 ]
Nishio, Kazuto [2 ]
机构：
[1] Kinki Univ, Sch Med, Dept Surg, Osaka 589, Japan
[2] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Axonal neuregulin signals the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
    Vartanian, T
    Goodearl, A
    Viehover, A
    Lees, M
    Fischbach, G
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S121 - S121
  • [32] Role of EGFR but not HER2 or HER3 gene copy number in predicting sensitivity of head and neck squamous cell carcinoma (SCCHN) cell lines to EGFR tyrosine kinase inhibitors
    Varella-Garcia, M.
    Acheson, K.
    Marshall, G. B.
    McCormack, R. M.
    Ryan, A.
    Hirsch, F. R.
    Bunn, P. A., Jr.
    Hickinson, D. M.
    Speake, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Effects of HER2 and HER3 on EGFR trafficking and localization - a modelling study
    Resat, H
    Shankaran, H
    Wiley, H
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 13A - 13A
  • [34] The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
    Memon, A. A.
    Sorensen, B. S.
    Meldgaard, P.
    Fokdal, L.
    Thykjaer, T.
    Nexo, E.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1703 - 1709
  • [35] The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
    A A Memon
    B S Sorensen
    P Meldgaard
    L Fokdal
    T Thykjaer
    E Nexo
    British Journal of Cancer, 2006, 94 : 1703 - 1709
  • [36] The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors
    Cirstea, Andreea-Elena
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Zavoi, Roxana Eugenia
    Olimid, Daniel Alin
    Simionescu, Cristiana Eugenia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (04): : 1269 - 1273
  • [37] Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines
    De Pauw, Ines
    Lardon, Filip
    Van den Bossche, Jolien
    Baysal, Hasan
    Fransen, Erik
    Deschoolmeester, Vanessa
    Pauwels, Patrick
    Peeters, Marc
    Vermorken, Jan Baptist
    Wouters, An
    MOLECULAR ONCOLOGY, 2018, 12 (06) : 830 - 854
  • [38] The upgraded role of HER3 and HER4 receptors in breast cancer
    Koutras, Angelos K.
    Fountzilas, George
    Kalogeras, Konstantine T.
    Starakis, Ioannis
    Iconomou, Gregoris
    Kalofonos, Haralabos P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 74 (02) : 73 - 78
  • [39] Distinct characteristics of heregulin signals mediated by HER3 or HER4
    Weiss, FU
    Wallasch, C
    Campiglio, M
    Issing, W
    Ullrich, A
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (02) : 187 - 195
  • [40] Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
    Vartanian, T
    Goodearl, A
    Viehover, A
    Fischbach, G
    JOURNAL OF CELL BIOLOGY, 1997, 137 (01): : 211 - 220
12345